






  





















































<!DOCTYPE html>
<html xmlns="https://www.w3.org/1999/xhtml" lang='en'>
<head>  
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="content-type" content="text/html; charset=UTF-8" />
    <meta name="robots" content="noindex,nofollow"/>
    <meta name="referrer" content="origin-when-cross-origin"/>
  <title>Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease - Tabular View - ClinicalTrials.gov</title>
    <link href="/ct2/show/record/NCT02319798" rel="canonical"/>
  
  <link rel="shortcut icon" href="/ct2/html/images/favicon.ico" />
  <link rel='apple-touch-icon-precomposed' href='/apple-touch-icon-144x144.png' sizes='144x144'>
  <link rel='apple-touch-icon-precomposed' href='/apple-touch-icon-114x114.png' sizes='114x114'>
  <link rel='apple-touch-icon-precomposed' href='/apple-touch-icon-72x72.png'   sizes='72x72'>
  <link rel='apple-touch-icon-precomposed' href='/apple-touch-icon-precomposed.png' >
  <link rel='apple-touch-icon-precomposed' href='/apple-touch-icon.png' >

  <link rel="stylesheet" type="text/css" href="/ct2/html/ct3/jquery/css/superfish.css" media="screen" />
  <link rel="stylesheet" type="text/css" href="/ct2/html/ct3/jquery/css/superfish-vertical.css" media="screen" />
  <link rel="stylesheet" type="text/css" href="/ct2/html/ct3/css/base.css?v=b4" />
  <link rel="stylesheet" type="text/css" href="/ct2/html/ct3/css/print.css" media="print" />
  <link rel="stylesheet" href="/ct2/html/ct3/css/w3-ct.css" type="text/css" />
  <!--[if lt IE 9]>
	<link rel="stylesheet" href="/ct2/html/ct3/css/w3-ct-oldIE.css" type="text/css" />
  <![endif]-->
  	

     <!--[if lte IE 7]>
           <link href="/ct2/html/ct3/css/target-IE7-and-below.css" rel="stylesheet" type="text/css">
    <![endif]-->

<link href="/ct2/html/ct3/css/trial-record.css?v=b4" rel="stylesheet" type="text/css" />
<link href="/ct2/html/ct3/css/ct2Header.css" rel="stylesheet" type="text/css" />


	<script type="text/javascript" src="/ct2/html/ct3/jquery/js/jquery.min.js?v=1.12.4"></script><noscript></noscript>
	    <script type="text/javascript" src="/ct2/html/ct3/jquery/js/superclick.js"></script><noscript></noscript>
    <script type="text/javascript" src="/ct2/html/ct3/jquery/js/jquery.cookie.js"></script><noscript></noscript>
    <script type="text/javascript" src="/ct2/html/images/frame/ct.js"></script><noscript></noscript>
    <script type="text/javascript" src="/ct2/html/ct3/js/ctmenu.js?v=b4"></script><noscript></noscript>

    <script type="text/javascript" src="/ct2/html/images/foresee/foresee-trigger.js"></script><noscript></noscript>
<script type="text/javascript">
    $(window).load(function(){
        loadCTCommon();
        });
</script>
 


  <script type="text/javascript">
    ncbi_pingWithImage=true;
    __ncbi_stat_url="//www.ncbi.nlm.nih.gov/stat";        
  </script>
  
  <meta name="ncbi_sid" content="861650e698601876_927f1SID"/>
  <meta name="ncbi_app" content="ctgov"/>
  <meta name="ncbi_db" content="ctgov"/>
  <meta name="ncbi_pdid" content="show_record"/>
  <meta name="ncbi_pcid" content="NCT02319798"/>
  <meta name="ncbi_ctreqid" content="RRe02WYR"/>
  <meta name="ncbi_ctsessid" content="SRe01hyp"/>
  <meta name="ncbi_ctipid" content="IzOkI5NS"/>
  <meta name="ncbi_cthost" content="wp2"/>
</head>

<body class="js one-column"> 
<div id="skip"> <a href="#main-content">Skip to Main Content</a> </div>

<script type="text/javascript">
	var RetractableBannerStateProperty = 'CT_NewsBannerState';
	
	ToggleBanner = function()
    {
        var theAccordion = $('#retractableBanner'); 
       	if (theAccordion.css("display") == "none") {
        		$('#showMore').css('visibility', 'hidden');
        	} else {
         		$('#showMore').css('visibility', 'visible');
        	}
        theAccordion.slideToggle({
            duration: 'fast',
            start: function(){
				            	if (typeof FuncReAlign !== 'undefined') {
            		$( "table.fixedHeader-floating" ).hide();
            	}
			},
            done: function(){
            	if (theAccordion.css("display") == "none") {
            		rememberRetractableBannerState('hide');
            	} else {
            		rememberRetractableBannerState('show');
            	}
            	if (typeof FuncReAlign !== 'undefined') {
                	FuncReAlign();  
            		$( "table.fixedHeader-floating" ).show();
            	}
            }
		});
    };
	    
	var rememberRetractableBannerState = function(newState) {
		try {
			sessionStorage.setItem(RetractableBannerStateProperty, newState);
		} catch (e) {}
	};

	$(window).ready(function(){
		try {
			var retractableBannerState = sessionStorage.getItem(RetractableBannerStateProperty);
					    if (retractableBannerState === null  || retractableBannerState === 'show') {
				ToggleBanner();
			}
		} catch (e) {};
	});
</script><noscript></noscript>
<div class="w3-container w3-center" style="padding:1.5ex 0.125in 0;background:#205493;color:white">
	<div style="font-weight:bold;">This site became the new ClinicalTrials.gov on June 19th. <a href="https://www.nlm.nih.gov/pubs/techbull/mj17/mj17_clinicaltrials_improve_usability.html" style="margin-left:1em;color:white;border-bottom-color:white;">Learn more.</a>
		<div id="showMore" style="float:right;cursor:pointer;border-bottom:1px dotted white;" onclick="ToggleBanner();">Show more <img src="/ct2/html/ct3/images/show-more.png" style="width:17px;"></div>
	</div>
	<div id="retractableBanner" style="margin-top:1ex;display:none;">We will be updating this site in phases. This allows us to move faster and to deliver better services.
		<div id="showLess" style="float:right;cursor:pointer;border-bottom:1px dotted white;" onclick="ToggleBanner();">Show less <img src="/ct2/html/ct3/images/show-less.png" style="width:17px;"></div>
	</div>
</div>
<div id="wrapper" style="padding-top:0;">  <div id="longAlert" class="w3-hide-small" style="background-color:papayawhip;font-size:small;margin-bottom:1.5ex;">
	<img src="/ct2/html/ct3/images/warning.png" alt="ClinicalTrials.gov Menu" style="max-width:0.8rem;cursor:pointer;"/>
    <b>IMPORTANT</b>: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study.  <a href="/ct2/about-site/disclaimer">Read more...</a>
</div>
<div id="shortAlert" class="w3-hide-medium w3-hide-large" style="background-color:papayawhip;font-size:small;margin-bottom:1.5ex;">
	<img src="/ct2/html/ct3/images/warning.png" alt="ClinicalTrials.gov Menu" style="max-width:0.8rem;cursor:pointer;"/>
    <b>IMPORTANT</b>: Talk with a trusted healthcare professional before volunteering for a study. <a href="/ct2/about-site/disclaimer">Read more...</a>
</div>

  
	<div id="header" style="float:left;"> <a href="/ct2/home" style="border-style:none;box-shadow:none;"><img src='/ct2/html/ct3/images/ct.gov-logo.png' alt='ClinicalTrials.gov' style='max-width:100%;' /></a><br />
    	<div id="tagline">A service of the U.S. National Institutes of Health</div>
  	</div>
					<div id="hamburger" class="w3-hide-medium w3-hide-large" style="float:right;border-width:0;display:block;margin-left:1em;padding:4px;"
			title="Show menus">
			<img src="/ct2/html/ct3/images/hamburgerMenuIcon.png" alt="ClinicalTrials.gov Menu" style="max-width:30px;cursor:pointer;" 
			 onclick="$('#global-nav-popupMenu').toggle();"/>
		</div>
		<div id="global-nav-popupMenu" class="w3-hide-medium w3-hide-large w3-modal w3-center" 
			 style="display:none;" onclick="$('#global-nav-popupMenu').hide();"> 			<div id="global-nav-popupMenu-content" class="w3-modal-content">
				<div class="w3-container">
				    <span onclick="$('#global-nav-popupMenu').hide();"
				      class="w3-closebtn">&times;</span>
					<ul class="sf-menu sf-vertical">
									<li class="first"><a href="/ct2/search/index">Find Studies<img src="/ct2/html/ct3/images/pulldown.png" alt="Find Studies Menu"></a>
			<ul>
                      <li                  ><a                  href="/ct2/home">New Search</a></li>
                      <li                  ><a         href="/ct2/search/advanced">Advanced Search</a></li>
                      <li                  ><a     href="/ct2/search/browse?brwse=cond_cat">See Studies by Topic</a></li>
                      <li                  ><a             href="/ct2/search/map">See Studies on Map</a></li>
                      <li class="new-group"><a           href="/ct2/help/how-find/index">How to Search</a></li>
                      <li                  ><a href="/ct2/help/how-use-search-results">How to Use Search Results</a></li>
                      <li                  ><a        href="/ct2/help/how-find/find-study-results">How to Find Results of Studies</a></li>
                      <li                  ><a          href="/ct2/help/how-read-study">How to Read a Study Record</a></li>
			</ul>
			</li>
			<li><a href="/ct2/about-studies">About Studies<img src="/ct2/html/ct3/images/pulldown.png" alt="About Studies Menu"></a>
			<ul>
                      <li><a href="/ct2/about-studies/learn">Learn About Studies</a></li>
                      <li><a  href="/ct2/about-studies/other-sites">Other Sites About Studies</a></li>
                      <li><a         href="/ct2/about-studies/glossary">Glossary of Common Site Terms</a></li>
			</ul>
			</li>
			<li><a href="/ct2/manage-recs">Submit Studies<img src="/ct2/html/ct3/images/pulldown.png" alt="Submit Studies Menu"></a>
			<ul>
                      <li><a                          href="/ct2/manage-recs/background">Why Should I Register and Submit Results?</a></li>
                      <li><a                                href="/ct2/manage-recs/fdaaa">FDAAA 801 Requirements</a></li>
                      <li class="new-group"><a    href="/ct2/manage-recs/how-apply">How to Apply for an Account</a></li>
                      <li><a                        href="/ct2/manage-recs/how-register">How to Register Your Study</a></li>
                      <li><a                         href="/ct2/manage-recs/how-edit">How to Edit Your Study Record</a></li>
                      <li><a                   href="/ct2/manage-recs/how-report">How to Submit Your Results</a></li>
                      <li class="new-group"><a       href="/ct2/manage-recs/faq">Frequently Asked Questions</a></li>
                      <li                  ><a href="/ct2/manage-recs/resources">Support Materials</a></li>
                      <li                  ><a      href="/ct2/manage-recs/present">Training Materials</a></li>
			</ul>
			</li>
			<li><a href="/ct2/resources">Resources<img src="/ct2/html/ct3/images/pulldown.png" alt="Resources Menu"></a>
			<ul>
                      <li                  ><a    href="/ct2/resources/pubs">Selected Publications</a></li>
                      <li                  ><a       href="/ct2/resources/alert">Clinical Alerts and Advisories</a></li>
                      <li                  ><a     href="/ct2/resources/rss">RSS Feeds</a></li>
                      <li class="new-group"><a href="/ct2/resources/trends">Trends, Charts, and Maps</a></li>
                      <li                  ><a   href="/ct2/resources/download">Downloading Content for Analysis</a></li>
			</ul>
			</li>
			<li class="last"><a href="/ct2/about-site">About Site<img src="/ct2/html/ct3/images/pulldown.png" alt="About Site Menu"></a>
			<ul>
                      <li class="new-group"><a href="/ct2/about-site/background">ClinicalTrials.gov Background</a></li>
                      <li                  ><a    href="/ct2/about-site/results">About the Results Database</a></li>
                      <li                  ><a    href="/ct2/about-site/history">History, Policies, and Laws</a></li>
                      <li                  ><a   href="/ct2/about-site/for-media">Media/Press Resources</a></li>
                      <li class="new-group"><a          href="/ct2/about-site/link-to">Linking to This Site</a></li>
                      <li                  ><a           href="/ct2/about-site/terms-conditions">Terms and Conditions</a></li>
                      <li                  ><a      href="/ct2/about-site/disclaimer">Disclaimer</a></li>
			</ul>
			</li>
					</ul>
				</div>
    		</div>
  		</div>		

	  	<div id="savedStudies" style="float:right;padding:4px 8px;"> 		  	<div id="cart" style="cursor:pointer;" onclick="location.href=('/ct2/results'+cartToURL()); showWorking();">
		  	<button class="savedStudiesEnabled" id="open-cart-link" type="button" 
		  		onclick="location.href=('/ct2/results'+cartToURL()); showWorking();"
		  		title="Show previously saved studies.">Saved Studies</button>
		  	</div>
			<button class="savedStudiesDisabled" id="cart-disabled" type="button" disabled
				title="There are no saved studies to show. You can save studies to visit later from the search results page">Saved Studies (0)</button>
		</div>

		<div style="clear:right;text-align:right;padding-top:1ex;padding-right:8px;font-size:small;">
			<a href="https://survey.foreseeresults.com/survey/display?cid=WyHFr2m0PoaGCBUsi00QIQ==&sid=link-ct" target="_blank">Give us feedback</a></div>
		<script type="text/javascript" src="/ct2/html/ct3/js/cart.js?v=b4"></script><noscript></noscript>
  	
<div id="global-nav" class="w3-hide-small">
	<ul class="sf-menu sf-vertical">
			<li class="first"><a href="/ct2/search/index">Find Studies<img src="/ct2/html/ct3/images/pulldown.png" alt="Find Studies Menu"></a>
			<ul>
                      <li                  ><a                  href="/ct2/home">New Search</a></li>
                      <li                  ><a         href="/ct2/search/advanced">Advanced Search</a></li>
                      <li                  ><a     href="/ct2/search/browse?brwse=cond_cat">See Studies by Topic</a></li>
                      <li                  ><a             href="/ct2/search/map">See Studies on Map</a></li>
                      <li class="new-group"><a           href="/ct2/help/how-find/index">How to Search</a></li>
                      <li                  ><a href="/ct2/help/how-use-search-results">How to Use Search Results</a></li>
                      <li                  ><a        href="/ct2/help/how-find/find-study-results">How to Find Results of Studies</a></li>
                      <li                  ><a          href="/ct2/help/how-read-study">How to Read a Study Record</a></li>
			</ul>
			</li>
			<li><a href="/ct2/about-studies">About Studies<img src="/ct2/html/ct3/images/pulldown.png" alt="About Studies Menu"></a>
			<ul>
                      <li><a href="/ct2/about-studies/learn">Learn About Studies</a></li>
                      <li><a  href="/ct2/about-studies/other-sites">Other Sites About Studies</a></li>
                      <li><a         href="/ct2/about-studies/glossary">Glossary of Common Site Terms</a></li>
			</ul>
			</li>
			<li><a href="/ct2/manage-recs">Submit Studies<img src="/ct2/html/ct3/images/pulldown.png" alt="Submit Studies Menu"></a>
			<ul>
                      <li><a                          href="/ct2/manage-recs/background">Why Should I Register and Submit Results?</a></li>
                      <li><a                                href="/ct2/manage-recs/fdaaa">FDAAA 801 Requirements</a></li>
                      <li class="new-group"><a    href="/ct2/manage-recs/how-apply">How to Apply for an Account</a></li>
                      <li><a                        href="/ct2/manage-recs/how-register">How to Register Your Study</a></li>
                      <li><a                         href="/ct2/manage-recs/how-edit">How to Edit Your Study Record</a></li>
                      <li><a                   href="/ct2/manage-recs/how-report">How to Submit Your Results</a></li>
                      <li class="new-group"><a       href="/ct2/manage-recs/faq">Frequently Asked Questions</a></li>
                      <li                  ><a href="/ct2/manage-recs/resources">Support Materials</a></li>
                      <li                  ><a      href="/ct2/manage-recs/present">Training Materials</a></li>
			</ul>
			</li>
			<li><a href="/ct2/resources">Resources<img src="/ct2/html/ct3/images/pulldown.png" alt="Resources Menu"></a>
			<ul>
                      <li                  ><a    href="/ct2/resources/pubs">Selected Publications</a></li>
                      <li                  ><a       href="/ct2/resources/alert">Clinical Alerts and Advisories</a></li>
                      <li                  ><a     href="/ct2/resources/rss">RSS Feeds</a></li>
                      <li class="new-group"><a href="/ct2/resources/trends">Trends, Charts, and Maps</a></li>
                      <li                  ><a   href="/ct2/resources/download">Downloading Content for Analysis</a></li>
			</ul>
			</li>
			<li class="last"><a href="/ct2/about-site">About Site<img src="/ct2/html/ct3/images/pulldown.png" alt="About Site Menu"></a>
			<ul>
                      <li class="new-group"><a href="/ct2/about-site/background">ClinicalTrials.gov Background</a></li>
                      <li                  ><a    href="/ct2/about-site/results">About the Results Database</a></li>
                      <li                  ><a    href="/ct2/about-site/history">History, Policies, and Laws</a></li>
                      <li                  ><a   href="/ct2/about-site/for-media">Media/Press Resources</a></li>
                      <li class="new-group"><a          href="/ct2/about-site/link-to">Linking to This Site</a></li>
                      <li                  ><a           href="/ct2/about-site/terms-conditions">Terms and Conditions</a></li>
                      <li                  ><a      href="/ct2/about-site/disclaimer">Disclaimer</a></li>
			</ul>
			</li>
	</ul>
    <div style="clear:both;"></div>
</div>
<div style="clear:both;"></div> 

<div id="utilities">
     
</div>
<div id="breadcrumb">
	<ul class="horz-list">
		<li><a href="/ct2/home">Home</a></li>
				<li class="last">Study Record Detail</li>
	</ul>
</div>


<div id="main-content">


        	<h1 class="solo_record">Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease</h1>
	<div id="trial-info-1" class="floater-50">

     


      
        <div  class="not-recruiting-status" >
      This study has been completed.
          </div>
        
        
      
        




                <div class="info-title">Sponsor:</div>
                <div class="info-text" id="sponsor"> Central Manchester University Hospitals NHS Foundation Trust </div>


                <div class="info-title">Collaborator:</div>
                 				   <div class="info-text">National Institute for Health Research, United Kingdom</div> 				
                              <div class="info-title">Information provided by (Responsible Party):</div>
                <div class="info-text">Athony Akobeng, Central Manchester University Hospitals NHS Foundation Trust</div>
              

            </div>
               <div id="trial-info-2" class="floater-50">
                <div class="info-title">ClinicalTrials.gov Identifier:</div>
                <div class="identifier">NCT02319798</div>
                <div class="info-date">First received: April 14, 2014</div>
                <div class="info-date">Last updated:  December 15, 2014</div>
                <div class="info-date">Last verified:  April 2014 </div>
                <div class="info-date"> <a href="/ct2/archive/NCT02319798"
          title="Historical versions of study NCT02319798 on ClinicalTrials.gov Archive Site - opens in new window"
          onclick="openNewWindow('/ct2/archive/NCT02319798'); return false;">History of Changes</a> </div>
            </div>



<div id="tabs">
        <ul id="tab-links">
			<li id="full-text" ><a href="/ct2/show/study/NCT02319798"  >Full Text View</a></li>
			<li id="tabular"     class="current"> Tabular View       </li>
			<li id="results"   ><a href="/ct2/show/results/NCT02319798">No Study Results Posted</a></li>
			<li id="disclaimer"><a href="/ct2/about-site/disclaimer">Disclaimer</a></li>
			<li id="howtoread"><a title="How to Read a Study Record - opens new window"  href="/ct2/help/how-read-study" onclick="openNewWindow('/ct2/help/how-read-study'); return false"
>How to Read a Study Record</a></li>
        </ul>
</div>  <div style="background-color:#f6f6f6;margin-top:3.5ex;padding-bottom:3.5ex;"> </div>




<!-- field list -->
<div class="indent1">
 
  <table class="w3-table data_table tableStyle">
    <tr>
      <th class="header2 banner_color sectionBanner" colspan="2">Tracking Information</th>
    </tr>
        <tr>
      <th class="header3 banner_color rowHeader">First Received Date&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody">April 14, 2014</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Last Updated Date </th>
            <td class="body3 rowBody">December 15, 2014</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Start Date&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody">July 2010</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Primary Completion Date </th>
            <td class="body3 rowBody">July 2013 &nbsp; (Final data collection date for primary outcome measure)</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Current Primary Outcome Measures&nbsp;<sup style="color:blue"> ICMJE </sup> <br/>&nbsp;<span class="footer">(submitted:&nbsp;December 15, 2014)</span></th>
            <td class="body3 rowBody">Changes in the paediatric IBD-specific health-related quality of life (QOL) scores. [&nbsp;Time&nbsp;Frame:&nbsp;6 monthly over 2 years&nbsp;]<div class="indent2" style="margin-top:1ex;">QOL scores will be assessed at baseline, and 6-monthly over the 2-year follow-up period using the validated paediatric IBD QOL IMPACT questionnaire</div></td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Original Primary Outcome Measures&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody"><i style="color:#777777">Same as current</i></td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Change History </th>
            <td class="body3 rowBody">No Changes Posted</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Current Secondary Outcome Measures&nbsp;<sup style="color:blue"> ICMJE </sup> <br/>&nbsp;<span class="footer">(submitted:&nbsp;December 15, 2014)</span></th>
            <td class="body3 rowBody">Relapses [&nbsp;Time&nbsp;Frame:&nbsp;All relapses over 2 years&nbsp;]<div class="indent2" style="margin-top:1ex;"><p style="margin-top:0ex; margin-bottom:1ex;">For each participant, the number of relapses during the study period will be recorded. For patients with Crohn&apos;s disease, a relapse will be defined as an aPCDAI of &gt;15. The aPCDAI consists of the three history items (abdominal pain, number of liquid stools, and general well-being), and the three physical examination items (weight loss, abdominal examination, and perirectal disease). Items in this index are scored on a three-point scale (zero, 5, or 10 points) and scores range from zero to 60 with higher scores indicating more active disease.</p>
<p style="margin-top:0ex; margin-bottom:1ex;">For patients with ulcerative colitis and indeterminate colitis, a PUCAI score of &gt;15 will be considered as a relapse. The PUCAI is a validated instrument that includes six history items (abdominal pain, rectal bleeding, stool consistency, nocturnal stools and activity level). PUCAI scores can range from zero to 85 with higher scores indicating more active disease.</p></div></td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Original Secondary Outcome Measures&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody"><i style="color:#777777">Same as current</i></td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Current Other Outcome Measures&nbsp;<sup style="color:blue"> ICMJE </sup> <br/>&nbsp;<span class="footer">(submitted:&nbsp;December 15, 2014)</span></th>
            <td class="body3 rowBody">Patient satisfaction with consultations [&nbsp;Time&nbsp;Frame:&nbsp;every appointment during study period ( over 2 years)&nbsp;]<div class="indent2" style="margin-top:1ex;">Participants or their carers will be asked to complete a Consultation Satisfaction Questionnaire (CSQ) at the end of each consultation. This CSQ is an 18 item consultation-specific satisfaction measure that was developed and validated by R Baker (Br J Gen Pract 1990;40:487-90. and Dialogue, 3rd edition. Clinical Governance Research and Development Unit, University of Leicester. 2001)</div></td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Original Other Outcome Measures&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody"><i style="color:#777777">Same as current</i></td>
          </tr>
    
    <tr><td colspan=2>&nbsp;</td></tr>

    <tr>
      <th class="header2 banner_color sectionBanner" colspan="2">Descriptive Information</th>
    </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Brief Title&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody">Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Official Title&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody">Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease: Randomised Controlled Trial and Economic Evaluation.</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Brief Summary </th>
            <td class="body3 rowBody"><p style="margin-top:1ex; margin-bottom:1ex;">Inflammatory bowel disease (IBD) refers to two chronic diseases (Crohn's disease and ulcerative colitis) that affect the intestines. The number of new cases of IBD in people younger than 16 years old has been increasing in the United Kingdom (UK), and is currently estimated to be 700 new cases every year. There is no cure for IBD and patients experience episodes of flareups in between periods of wellbeing.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Traditionally, children with IBD are asked to attend regular hospital appointments. This means that, even if they are well, they have to get to the hospital and this can involve travelling long distances.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Telephone consultations have been shown to be beneficial in some areas of medicine but this approach has not been well studied in children. The aims of this study are to determine whether telephone consultations would improve quality of life, patient satisfaction, proportion of consultations attended and whether they would be safe and reduce costs for patients and the National Health Service (NHS). Investigators plan a randomised controlled trial involving 92 participants recruited from amongst the 250 children and adolescents aged between 8 and 16 years who attend the regional paediatric IBD centre in Manchester. Half will be assigned to telephone consultations, and half to face to face consultations. The study would have the approval of the local ethics committee and participants would have provided written consent. Investigators will compare outcomes in the two groups over 2 years. If telephone consultations prove to be effective, the NHS could offer children with IBD the choice of either telephone consultation or face to face consultation for their outpatient followup. Those who are doing well would not have to make unnecessary journeys to the hospital. This would free up clinic spaces and allow patients who are unwell, and new patients to be seen more quickly, thus reducing waiting</p></td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Detailed Description </th>
            <td class="body3 rowBody"><p style="margin-top:1ex; margin-bottom:1ex;">HYPOTHESIS Telephone consultation is effective, safe, and a cost-effective alternative to traditional routine face-to-face consultation for children and adolescents with IBD.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">AIMS</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The specific aims of the study are:</p>
  <ol style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">
      <p style="margin-top:0ex; margin-bottom:1ex;">To determine if telephone consultation, compared to face-to-face consultation is effective for children and adolescents with IBD.</p>
      <p style="margin-top:0ex; margin-bottom:1ex;">The investigators hypothesise that compared to face-face-consultations, telephone consultations would:</p>
      <ol style="margin-top:1ex; margin-bottom:1ex;">
        <li style="margin-top:0.7ex;">improve patients' health-related quality of life</li>
        <li style="margin-top:0.7ex;">have a positive impact on patient/carer satisfaction with consultations</li>
        <li style="margin-top:0.7ex;">reduce out-patient non-attendance rate</li>
      </ol>
    </li>
    <li style="margin-top:0.7ex;">
      <p style="margin-top:0ex; margin-bottom:1ex;">To determine any adverse events associated with routine telephone consultations in children and adolescents with IBD.</p>
      <p style="margin-top:0ex; margin-bottom:1ex;">The investigators hypothesise that compared to face-to-face consultations, telephone consultations will not:</p>
      <ol style="margin-top:1ex; margin-bottom:1ex;">
        <li style="margin-top:0.7ex;">adversely affect patients' disease course such as the number of relapses, number of hospital admissions, and number of times they have to visit their paediatrician or General Practitioner (GP) because of concerns about symptoms</li>
        <li style="margin-top:0.7ex;">adversely affect the child's growth</li>
      </ol>
    </li>
    <li style="margin-top:0.7ex;">To compare NHS resource utilisation, costs to the NHS and costs to patients and their carers in the two groups.</li>
  </ol>
  <p style="margin-top:0ex; margin-bottom:1ex;">The investigators hypothesise that telephone consultations, compared to face-to-face consultations, will:</p>
  <ol style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">reduce NHS resource use</li>
    <li style="margin-top:0.7ex;">reduce out-patient non-attendance rate</li>
    <li style="margin-top:0.7ex;">be cost-effective to the NHS and</li>
    <li style="margin-top:0.7ex;">reduce IBD-related costs for patients and families.</li>
  </ol>
  <p style="margin-top:0ex; margin-bottom:1ex;">METHODS SETTING AND PARTICIPANTS The study will be based at the Royal Manchester Children's Hospital, a regional Paediatric Gastroenterology referral centre. Children and adolescents with IBD from the North West of England and beyond are referred to this centre. Any patient who is aged between 8 and 16 years with a diagnosis of IBD will be eligible for entry into the trial. Eligible patients will be identified through the hospital's paediatric IBD database. There are currently about 250 eligible patients who attend the centre. Inclusion criteria are: patients aged between 8 and 16 years; diagnosis of IBD by established clinical, endoscopic, histological and radiological criteria; clinical remission defined as an abbreviated Paediatric Crohn's Disease Activity Index (aPCDAI) score of &#8804;10 (12) for patients with Crohn's disease or as a Paediatric Ulcerative Colitis Activity Index (PUCAI) score of &lt;10 (13) for those with ulcerative colitis and indeterminate colitis; parental and child's consent to participate in the study. Exclusion criteria are active disease (aPCDAI&gt;15 or PUCAI &#8805;15), and unwillingness to provide informed consent.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">STUDY DESIGN A randomised controlled trial comparing telephone consultations with standard face-to-face out-patient consultations. It will be accompanied by an economic evaluation.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">PLAN OF STUDY The investigators will send a letter of invitation to participate in the study and a research information sheet outlining the nature and importance of the study to eligible patients and their parents. The invitation letter will explicitly state that if they do not wish to take part in the study, it will not prejudice the quality of health care provision from the hospital. Two weeks later, the investigators will telephone all those who have not already responded, offering an invitation to participate and to answer any queries. Those who can not be contacted by telephone will be sent a second letter. Those who agree to take part will be interviewed by an investigator who will provide full information about the trial and obtain written informed consent. Prior to randomization, the following baseline demographic and clinical features will be recorded: patient's initials, date of birth, gender, hospital number, and disease activity (aPCDAI or PUCAI score). Participants will be provided with the contact details of relevant investigators.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Randomization</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">By means of a computer-generated random number, participants will be randomly allocated to one of two groups:</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Intervention Group: telephone consultations Control Group: face-to-face consultations</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The investigators will use a stratified block randomization with blocks of random sizes, and stratify by type of disease (i.e.Crohn's disease or ulcerative colitis/indeterminate colitis).</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">To ensure allocation concealment, the computer-generated assignment schedule will be held centrally and administered by 2 designated administrators who are not involved in the study. If a participant meets the inclusion criteria and provides informed consent, he or she will be entered into the study. Investigators will telephone the designated administrators, who after recording the patient's identification number, date of birth and disease activity score, will assign the next number in the series to determine allocation group. The assigned group will be recorded and implemented. Nobody will be able to alter the assignment. Participants in the telephone group will, however, retain the option to return to routine care through non-concordance with the allocated intervention.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Procedures Patients in both groups will be offered out-patient appointment dates and times. Those randomized to face-to-face follow up will attend their appointments in hospital as usual. Those randomized to telephone consultation will be told to expect a call from the gastroenterology doctor at the time of their appointment (which will be after school hours). The consulting doctor will contact the patient and parents via a telephone number (home or mobile) that the parents and patient had previously supplied as the number they would like to be contacted on. As much as possible, parents and patients will be advised to be together at the time of the appointment in order to allow both of them to participate in the consultation as is usual in practice. Up to 3 attempts within 20 minutes will be made to contact patients by phone. Details about each consultation including date and time, who was present, duration of consultations, and failed attempts at phone calls will be recorded. Patients who &quot;DNA&quot; an appointment in either group will be sent another appointment in accordance with normal practice.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Apart from being randomised to telephone or face-to-face consultation, routine care will be the same for patients in both groups. For instance, all patients on treatments such as azathioprine and methotrexate will continue to have relevant tests such as full blood count and liver function tests monitored regularly according to current guidelines. In our current practice, this routine monitoring does not usually take place at the routine out-patient visits but rather at the child's GP surgery, or local hospital and the results communicated to our inflammatory bowel disease nurse specialists. This practice will remain the same for all patients. It will also be emphasized that, as it is in normal practice, if a participant experiences any symptoms that cause concern at any time during the study, the parent/child should contact the IBD nurse for advice and an appropriate arrangement for assessment will be made. A relapse will not require withdrawal but the patient will be seen and treated as appropriate and will remain in the same study group.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">OUTCOME MEASURES Primary outcome measure The primary outcome measure will be changes in the paediatric IBD-specific health-related quality of life (QOL) scores. QOL scores will be assessed at baseline, and 6-monthly over the 2-year follow-up period using the validated paediatric IBD QOL IMPACT questionnaire (Appendix 1). The IMPACT questionnaire was originally developed for use in paediatric IBD in Canada (14) and with minor adaptations, the questionnaire was subsequently validated in Canada ((15), the Netherlands (16), and the UK (17). The questionnaire consists of 35 questions measuring six quality of life domains (IBD symptoms, systemic symptoms, emotional functioning, social functioning, body image, and treatment/interventions) and utilizes a Likert scale to report the patient's answers. Responses are scored (from 0 to 4) and summed to give a total score (range 0 to 140). Higher scores represent better QOL.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Secondary outcome measures</p>
  <ol style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">
      <p style="margin-top:0ex; margin-bottom:1ex;">Relapses For each participant, the number of relapses during the study period will be recorded. For patients with Crohn's disease, a relapse will be defined as an aPCDAI of &gt;15. The PCDAI was originally developed and validated in several centres (18) and has been used widely in paediatric clinical trials. The original PCDAI includes three history items (abdominal pain, number of liquid stools, general wellbeing), five physical examination items (abdominal examination, perirectal disease, extraintestinal manifestations, weight, height velocity), and three laboratory tests (hematocrit, albumin, erythrocyte sedimentation rate). Among other things, the original PCDAI has been criticized because of the inclusion of blood tests. Recent studies have shown that an abbreviated version of the PCDAI (aPCDAI) which omits laboratory items is accurate and predicted disease activity as well as the original PCDAI (12,19). The aPCDAI consists of the three history items (abdominal pain, number of liquid stools, and general well-being), and the three physical examination items (weight loss, abdominal examination, and perirectal disease) of the original PCDAI. In order to avoid repeated blood sampling for research purposes, we will use the aPCDAI (Appendix II). Items in this index are scored on a three-point scale (zero, 5, or 10 points) and scores range from zero to 60 with higher scores indicating more active disease.</p>
      <p style="margin-top:0ex; margin-bottom:1ex;">For patients with ulcerative colitis and indeterminate colitis, a PUCAI score of &gt;15 will be considered as a relapse. The PUCAI is a validated instrument that includes six history items (abdominal pain, rectal bleeding, stool consistency, nocturnal stools and activity level) (13). PUCAI scores can range from zero to 85 with higher scores indicating more active disease.</p>
    </li>
    <li style="margin-top:0.7ex;">Basic anthropometric measures at every routine follow up visit / consultation Weight and height will be measured at baseline and during the routine follow up appointments in both groups. For those allocated to face to face consultations, their height and weight will be measured at their out-patients visits. For children allocated to telephone consultations, height and weight will be measured by their local paediatric service, prior to their telephone appointment. A member of the study team will, prior to each follow up period, contact those in the telephone consultation group to remind them to the have measurements done. A study team member will then contact the local service or the parent / patient to obtain the measurements. Height and body mass index (BMI) z scores will be calculated based on sex- and age-related UK centile charts.</li>
    <li style="margin-top:0.7ex;">Patient satisfaction with consultations - to be completed after every Participants or their carers will be asked to complete a Consultation Satisfaction Questionnaire (CSQ) at the end of each consultation. This CSQ is an 18 item consultation-specific satisfaction measure that was developed and validated by Baker (20, 21). It has since been used in other areas/settings including community nursing (22, 23), and has recently been modified and tested for use in consultations involving patients aged 15 years or younger (24). After discussions with the originator of this instrument and the researcher who modified it for paediatric use, the modified version of the CSQ will be adapted for children aged 15 years and younger (Appendix IIa), and the original version adapted for patients aged 16 years or older (Appendix IIb) {R Baker and P Kinnersley, personal communication, July 2008}.</li>
    <li style="margin-top:0.7ex;">Number of hospital admissions for IBD over 24 months. Data will be obtained from the patient's hospital records.</li>
    <li style="margin-top:0.7ex;">Proportion of out-patient consultations attended For each group, the proportion of outpatient appointments attended over the 24-month follow-up period will be calculated by dividing the total number of appointments (telephone or face-to-face) offered by the number of appointments attended.</li>
    <li style="margin-top:0.7ex;">Duration of consultations The duration of each consultation will be recorded in the patient's medical notes.</li>
    <li style="margin-top:0.7ex;">
      <p style="margin-top:0ex; margin-bottom:1ex;">Adverse effects of immuno-suppressive agents such as azathioprine and methotrexate.</p>
      <p style="margin-top:0ex; margin-bottom:1ex;">Any adverse effect of immuno-suppressive agents that participants may be receiving during the study period will be recorded.</p>
    </li>
    <li style="margin-top:0.7ex;">Economic evaluation Investigators will assess the use of health care resources, costs to the NHS and costs to patients and their carers in the two groups. Data on resource use in tertiary, secondary and primary care will be collected. Data on resources used for outpatient consultations (telephone or face-to-face), additional or unscheduled hospital visits, tests and procedures, drug prescriptions, hospital admissions, and general practice visits will be identified for every patient.</li>
  </ol>
  <p style="margin-top:0ex; margin-bottom:1ex;">At each outpatient consultation (telephone or face-to-face), the clinician will record details of the consultation including date of the visit and duration of the consultation. Abortive telephone calls will be recorded as well as face-to-face appointments missed. For telephone consultations, it will be noted whether calls were local, national, or made to mobile phones. Data on inpatient admissions, any investigations or procedures, and treatments received will be abstracted from the patient's hospital records. A patient/carer diary (Appendix IV) will be used to collect information on drug utilisation (name, dose, frequency, and duration), GP visits, and care received at other hospitals. Patients will be asked to complete the diary every time they visited their GP, changed their regular medications, or were seen at other hospitals. Diary information will be collated 6-monthly. Resource use that was clearly unrelated to IBD will be excluded from the economic evaluation.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Note:Routine follow ups / consultations vary between patients depending on how well they are. Patients may also be seen for routine appointments in between the scheduled study follow ups.</p></td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Study Type&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody">Interventional</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Study Phase </th>
            <td class="missing_color">Not Provided</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Study Design&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody">Allocation: Randomized<br/>Intervention Model: Parallel Assignment<br/>Masking: Open Label</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Condition&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody"><ul style="margin:0ex 1em; padding:0ex 0em">
<li style="margin:1ex 0.5ex">Crohn's Disease</li>
<li style="margin:1ex 0.5ex">Ulcerative Colitis</li>
</ul>
</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Intervention&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody"><ul style="margin:0ex 1em; padding:0ex 0em">
<li style="margin:1ex 0.5ex">Other: telephone consultations
<div class="indent2" style="margin-top:0.5ex">Those randomized to telephone consultation will be told to expect a call from the gastroenterology doctor at the time of their appointment.</div></li>
<li style="margin:1ex 0.5ex">Other: face-to-face consultations
<div class="indent2" style="margin-top:0.5ex">Those randomized to face-to-face follow up will attend their appointments in hospital</div></li>
</ul>
</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Study Arms </th>
            <td class="body3 rowBody"><ul style="margin:0ex 1em; padding:0ex 0em">
<li style="margin:1ex 0.5ex">Active Comparator: face-to-face consultations
<div class="indent2" style="margin-top:0.5ex">Those randomized to face-to-face follow up will attend their appointments in hospital as usual.</div>
<div class="indent2" style="margin-top:0.5ex">Intervention: Other: face-to-face consultations</div></li>
<li style="margin:1ex 0.5ex">Experimental: telephone consultations
<div class="indent2" style="margin-top:0.5ex">Those randomized to telephone consultation will be told to expect a call from the gastroenterology doctor at the time of their appointment.</div>
<div class="indent2" style="margin-top:0.5ex">Intervention: Other: telephone consultations</div></li>
</ul>
</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Publications * </th>
            <td class="body3 rowBody"><a class="study-link" href="/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR0BLR4jaR08A6h9Ei4L3BUgWwNG0it." onclick="openNewWindow('/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR0BLR4jaR08A6h9Ei4L3BUgWwNG0it.'); return false">Akobeng AK, O'Leary N, Vail A, Brown N, Widiatmoko D, Fagbemi A, Thomas AG. Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease: Randomised Controlled Trial and Economic Evaluation. EBioMedicine. 2015 Aug 8;2(9):1251-6. doi: 10.1016/j.ebiom.2015.08.011. eCollection 2015 Sep.</a></td>
          </tr>
    
    <tr>
      <td class="header3" style="padding-left:2em" colspan="2">
        <br/>
        * &nbsp; Includes publications given by the data provider as well as publications
        identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
      </td>
    </tr>

    <tr><td colspan=2>&nbsp;</td></tr>

    <tr>
      <th class="header2 banner_color sectionBanner" colspan="2">Recruitment Information</th>
    </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Recruitment Status&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody">Completed</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Enrollment&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody">86</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Completion Date </th>
            <td class="body3 rowBody">January 2014</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Primary Completion Date </th>
            <td class="body3 rowBody">July 2013 &nbsp; (Final data collection date for primary outcome measure)</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Eligibility Criteria&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody"><p style="margin-top:1ex; margin-bottom:1ex;">Inclusion Criteria:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">patients aged between 8 and 16 years</li>
    <li style="margin-top:0.7ex;">diagnosis of IBD by established clinical, endoscopic, histological and radiological criteria</li>
    <li style="margin-top:0.7ex;">clinical remission defined as an abbreviated Paediatric Crohn's Disease Activity Index (aPCDAI) score of &#8804;10 for patients with Crohn's disease or as a Paediatric Ulcerative Colitis Activity Index (PUCAI) score of &lt;10 for those with ulcerative colitis and indeterminate colitis</li>
    <li style="margin-top:0.7ex;">parental and child's consent to participate in the study.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">Exclusion Criteria:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">active disease (aPCDAI&gt;15 or PUCAI &#8805;15)</li>
    <li style="margin-top:0.7ex;">unwillingness to provide informed consent.</li>
  </ul></td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Sex/Gender </th>
            <td class="body3 rowBody"><table class="layout_table" cellpadding="0" cellspacing="0" style="border:none;">
  <tr valign="top">
   <td style="padding:0px; margin:0ex; border:none;" nowrap>Sexes Eligible for Study:</td>
   <td style="padding:0px 0px 0px 1em; margin:0ex; border:none;">All</td>
  </tr>
</table>
</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Ages </th>
            <td class="body3 rowBody">8 Years to 16 Years &nbsp; (Child)</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Accepts Healthy Volunteers </th>
            <td class="body3 rowBody">No</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Contacts&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody"><i style="color:#777777">Contact information is only displayed when the study is recruiting subjects</i></td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Listed Location Countries&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody">United Kingdom</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Removed Location Countries </th>
            <td class="body3"> &nbsp; </td>
          </tr>
    
    <tr><td colspan=2>&nbsp;</td></tr>

    <tr>
      <th class="header2 banner_color sectionBanner" colspan="2">Administrative Information</th>
    </tr>
        <tr>
      <th class="header3 banner_color rowHeader">NCT Number&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody">NCT02319798</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Other Study ID Numbers&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody">IBDV227APR2010</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Has Data Monitoring Committee </th>
            <td class="missing_color">Not Provided</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">U.S. FDA-regulated Product </th>
            <td class="missing_color">Not Provided</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">IPD Sharing Statement </th>
            <td class="missing_color">Not Provided</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Responsible Party </th>
            <td class="body3 rowBody">Athony Akobeng, Central Manchester University Hospitals NHS Foundation Trust</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Study Sponsor&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody">Central Manchester University Hospitals NHS Foundation Trust</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Collaborators&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="body3 rowBody">National Institute for Health Research, United Kingdom</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Investigators&nbsp;<sup style="color:blue"> ICMJE </sup> </th>
            <td class="missing_color">Not Provided</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">PRS Account </th>
            <td class="body3 rowBody">Central Manchester University Hospitals NHS Foundation Trust</td>
          </tr>
        <tr>
      <th class="header3 banner_color rowHeader">Verification Date </th>
            <td class="body3 rowBody">April 2014</td>
          </tr>
    
    <tr>
      <td class="header3" style="padding-left:2em" colspan="2">
        <br/>
        <sup style="color:blue"> ICMJE </sup>&nbsp; &nbsp; Data element required by the
        <a href="http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html">
        International Committee of Medical Journal Editors</a> and the
        <a href="http://www.who.int/ictrp/network/trds/en/index.html">World Health Organization ICTRP</a>
      </td>
    </tr>

  </table>
</div>


<div id="to-top"><a href="#wrapper">To Top</a></div>

	<div style="clear:both;"></div>
</div> 

      <div id="for-footer">
        <ul class="horz-list">
            <li style="border-left:0;"><a    href="/ct2/help/for-patient">For Patients and Families</a></li>
            <li><a href="/ct2/help/for-researcher">For Researchers</a></li>
            <li><a     href="/ct2/help/for-manager">For Study Record Managers</a></li>
        </ul>
    </div>

<div id="footer-menu">
    <ul class="horz-list">
		<li><a href="/ct2/home" style="white-space:nowrap">Home</a></li>
		<li><a     href="/ct2/resources/rss" style="white-space:nowrap">RSS Feeds</a></li>
		<li><a         href="/ct2/sitemap" style="white-space:nowrap">Site Map</a></li>
		<li><a       href="/ct2/about-site/terms-conditions" style="white-space:nowrap">Terms and Conditions</a></li>
		<li><a href="/ct2/about-site/disclaimer" style="white-space:nowrap">Disclaimer</a></li>
		<li><a        href="https://support.nlm.nih.gov/ics/support/KBList.asp?folderID=146?style=classic&amp;deptID=28054&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Frecord%2FNCT02319798" style="white-space:nowrap" onclick="openNewWindow('https://support.nlm.nih.gov/ics/support/KBList.asp?folderID=146?style=classic&amp;deptID=28054&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Frecord%2FNCT02319798'); return false">Customer Support</a></li>
	</ul>
</div>

</div>  
<div id="fine-print">
	<ul class="horz-list">
		<li                  ><a title="NLM copyright information - opens new window"  href="https://www.nlm.nih.gov/copyright.html" onclick="openNewWindow('https://www.nlm.nih.gov/copyright.html'); return false"
>Copyright</a></li>
		<li                  ><a title="NLM privacy policy - opens new window"  href="https://www.nlm.nih.gov/privacy.html" onclick="openNewWindow('https://www.nlm.nih.gov/privacy.html'); return false"
>Privacy</a></li>
		<li                  ><a href="/ct2/accessibility" title="NLM Accessibility">Accessibility</a></li>
		<li                  ><a title="NLM viewers and players - opens new window"  href="https://www.nlm.nih.gov/plugins.html" onclick="openNewWindow('https://www.nlm.nih.gov/plugins.html'); return false"
>Viewers and Players</a></li>
		<li                  ><a title="NIH Freedom of Information Act office - opens new window"  href="https://www.nih.gov/icd/od/foia/index.htm" onclick="openNewWindow('https://www.nih.gov/icd/od/foia/index.htm'); return false"
>Freedom of Information Act</a></li>
		<li class="last-item"><a title="USA.gov - opens new window"  href="https://www.usa.gov/" onclick="openNewWindow('https://www.usa.gov/'); return false"
>USA.gov</a></li>
	</ul>
    <ul class="horz-list">
       <li><a title="U.S. National Library of Medicine - opens new window"  href="https://www.nlm.nih.gov/" onclick="openNewWindow('https://www.nlm.nih.gov/'); return false"
>U.S. National Library of Medicine</a></li>
       <li><a title="U.S. National Institutes of Health - opens new window"  href="https://www.nih.gov/" onclick="openNewWindow('https://www.nih.gov/'); return false"
>U.S. National Institutes of Health</a></li>
       <li class="last-item"><a title="U.S. Department of Health and Human Services - opens new window"  href="https://www.hhs.gov/" onclick="openNewWindow('https://www.hhs.gov/'); return false"
>
            U.S. Department of Health and Human Services</a></li>
    </ul>
</div>

    <script type="text/javascript" src="/ct2/html/ct3/js/instrumentNCBIBaseJS.min.js"></script><noscript></noscript>

</body>
</html>
